News

The CE Mark gives Intrinsic approval to distribute the Barricaid throughout the EU and in other countries that recognize the CE Mark. According to Intrinsic Therapeutics, the Barricaid

The financing will underwrite the completion of Serdaxin’s subsequent trials required to bring the treatment through regulatory approval and then to patients. The funding for the development of

In the first phase of this collaboration, the companies will test the feasibility of smart patch-based transdermal delivery of a peptide drug candidate in animal models. Upon completion

Data was compiled at 12 and 24 months for 593 patients and 177 patients respectively from the registry study, which enrolled a broad spectrum of patients, including those

US-based RegeneRx Biopharmaceuticals has entered into a purchase agreement with an affiliate of the company’s largest stockholder, Sigma-Tau Group, with respect to the sale of 1.05 million shares

Most recently, Mr Mathias has served as vice president of marketing and business development at Alimentary Health, a biotechnology company. Prior to Alimentary Health, Mr Mathias was director

According to Dendreon, the magnitude of the survival difference observed in the intent to treat population resulted in the study successfully achieving the pre-specified level of statistical significance

The FDA has 30 days to review Tekmira’s investigational new drug (IND) application and to request any additional information before allowing the clinical trial to proceed. Tekmira will

Nanobac Pharmaceuticals, a research-based, bio-lifescience company, and Eureka Genomics, a provider of next generation sequencing, have signed a definitive merger agreement, which delineates the terms and conditions under